Komaki, Y <br/><br/>
Editorial: CT-P13, a biosimilar of anti-tumour necrosis factor-alpha agent (infliximab), in inflammatory bowel diseases - authors' reply.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  05 2017 
 - 1372 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/apt.14060  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal<br/>Biosimilar Pharmaceuticals<br/>Humans<br/>Inflammatory Bowel Diseases<br/>Infliximab<br/>Tumor Necrosis Factor-alpha